90 If possible, bring a healthy dish to share that aligns with dietary goals
Understanding GLP-1 Agonists: Key Insights for Payers By: Emily Crisano PharmD, RPh , and Jason Peterson, RPh , RPh The rapid adoption of GLP-1 treatments underscores their significance in modern therapeutic practices, making it imperative for payers, healthcare providers and consumers to stay informed about their evolving uses and market dynamics
Bethanechol remains the preferred drug in suspected underactive bladder: findings from nation-wide prescription analysis
7 Mitochondrial metabolism does not predict poor outcomes following surgery alone
"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Diabetes, Obesity and Metabolism
Collective efforts and initiatives like the Human Cell Atlas ( powered by single-cell technologies, will provide access to a catalogue of all cell types and their subtypes for the whole of the human body